from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3223c/sigH

LFCtreatmentdescriptionclass of inhibitor

-0.100

Amikacinug/mL Amikacintranslation

1.020

Cap5-10ug/mL Capreomycintranslation

1.157

Rox10-50 ug/mL Roxithromycintranslation

0.039

SM2-5 ug/mL Streptomycintranslation

1.438

Tet5-10 ug/mL Tetracyclinetranslation

-1.148

Rif0.2-5ug/mL Rifampicintranscription

-0.894

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.505

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.182

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.734

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.564

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.427

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.568

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.131

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.004

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.537

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.736

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.972

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.258

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.609

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.415

KCN5-20 ug/mL Potassium cyaniderespiration

-0.189

NaN30.2-2 mM Sodium aziderespiration

0.789

Nigericin50 uM Nigericinrespiration

0.571

TRC10-150 ug/mL Triclosanrespiration

-0.349

TRZ10-25 ug/mL Thioridazinerespiration

-0.232

Valinomycin0.5-10 uM Valinomycinrespiration

-0.062

ZnSO42 mM ZnSO4respiration

2.649

menadione6-10 ug/mL Menadionerespiration

-1.066

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.451

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.730

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.456

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.456

NRP_1Non-replicating persistence stage 1dosRassociated

-0.227

Amp0.2mg/mL AmpicillincellWall

-0.756

Cephalexin20-100 ug/mL CephalexincellWall

-0.320

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.616

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.536

EMB10-20 ug/mL EthambutolcellWall

-0.180

Eta12-40 ug/mL EthionamidecellWall

-0.041

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.022

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.458

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.676

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.089

BZA0.12 mg/mL BenzamidearomaticAmides

0.961

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.916

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.241

H2O24 mM hydrogen peroxideDNAdamaging

0.581

Levo10 ug/mL LevofloxacinDNAdamaging

0.070

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.164

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.360

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.184

UVUV-irradiationDNAdamaging

2.624

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.778

Antimycin12.5-50 ug/mL Antimycin A?

-0.346

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.948

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.849

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.173

PA8240.2-2 ug/mL PA-824?

-0.589

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.578

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.681

Verapamil50 uM Verapamil?

-0.403

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.477

methoxatin10-20 ug/mL Methoxatin?